Advance Online
The hands of a man with psoriatic arthritis on a wooden table, showing deformities in the fingers.
Advance Online

Psoriatic Arthritis or Rheumatoid Arthritis?

Dr. Cassandra Calabrese explains the similarities and differences between PsA and RA.

Prominent morning stiffness, swelling, redness, and warmth of the joints – these are all indicators that you may have inflammatory arthritis. The question is, what kind?

While rheumatoid arthritis (RA) might come to mind first, psoriatic arthritis (PsA) is more common than you might think. Among those living with psoriasis, about 1 in 3 will develop PsA, and it can happen at any age. 

Both RA and PsA result in inflammation inside the lining of the joints, and both involve the immune system. A number of key differences, however, can help health care providers distinguish one from the other. Cleveland Clinic rheumatologist Cassandra Calabrese, D.O., discussed the two diseases and how they differ. 

Diagnosis and Differentiators

There is currently no blood test for PsA, but in general, the joint pain and swelling for PsA would be asymmetric, involving potentially fewer joints, and typically would involve different joints than RA, says Dr. Calabrese.

“Not every patient with psoriasis and joint pain has psoriatic arthritis, but if there's new joint pain, worsening joint pain, or joint pain that's interfering with daily activities, then that patient should see a rheumatologist,” she recommends. 

PsA involves the entheses, which is where tendons connect to bones. This means that areas such as the back of the heel where the Achilles tendon inserts, or above the knee where the patellar tendon inserts, are common sources of pain for those with PsA, says Dr. Calabrese. Other areas more common in PsA, she says, include the lower spine and the distal interphalangeal (DIP) joints, the joints closest to the tips of the fingers and toes. Unique to PsA is dactylitis, or the so-called “sausage digit,” where an individual finger or toe will swell along the full digit without prior physical trauma. 

PsA, of course, frequently coincides with psoriasis, although Dr. Calabrese says the presence of psoriatic lesions isn’t necessary for a PsA diagnosis. PsA has additional indicators that don’t involve the joints, she says, including uveitis, or swelling of the eye, and changes in the fingernails and toenails. Typical nail changes are pitting of the nail, discoloration – either yellow or white – or spots underneath the nail, as well as nails that are detached, or lifted from the nail bed. Dr. Calabrese points out that these nail changes can often mimic fungal diseases, so it is important to discuss them with a dermatologist as well. 

Diagnosis for RA is often more straightforward. “The majority of cases have positive autoantibodies, so [these are] blood markers called rheumatoid factor and anti-CCP [anti-cyclic citrullinated peptide] antibody that test positive,” says Dr. Calabrese.

Unlike PsA, RA has symmetric joint involvement, typically with small joints such as the fingers, wrists, ankles, and elbows. While RA can affect the spine, it is typically focused in the upper spine. RA rarely involves the lower spine or the DIP joints, which are most common in PsA.  

For both types of inflammatory arthritis, “the diagnosis is based on patient history of joint swelling and pain,” says Dr. Calabrese, including any family history of joint disease. “The doctor might order blood tests looking for evidence of inflammation, X-rays to see a specific kind of damage from joint inflammation, and then sometimes an MRI [magnetic resonance imaging] or an ultrasound of the joint is needed to actually show the acute inflammation,” she adds. 

Treatment and Management

While many with joint pain may use over-the-counter pain relievers, “both rheumatoid arthritis and psoriatic arthritis are systemic diseases,” Dr. Calabrese explains. “They're not just diseases of the joint or diseases of the skin. The inflammation that's occurring in the skin and the joints is also affecting the whole body in a way that is harmful. Having untreated psoriatic arthritis is actually the cardiovascular risk equivalent of having diabetes in terms of increasing your risk for heart attack and stroke.” 

Treatments for PsA and RA are similar and involve systemic therapy that impacts the immune system. A common treatment type is a biologic. A biologic targets specific parts of the immune system, compared with traditional systemic drugs that impact the entire immune system. Dr. Calabrese explains that some biologics are indicated for both inflammatory arthritis types, but others impact immune system components specific to RA or PsA.  

Dr. Calabrese emphasizes how important it is to treat these diseases. “Not only does it treat pain and [skin lesions] from psoriasis – [treatment] prevents progression and permanent damage to the joints and other affected parts,” she says. “It lowers cardiovascular risk and has many other positive health outcomes.”  

Left untreated, inflammatory arthritis can cause permanent damage to the joints, called erosion. For some people, decades of untreated PsA have resulted in the need for joint replacement surgery. This is something that Dr. Calabrese says should no longer be the case in the “biologics era” of PsA treatment. “[We have] tools in our toolbox to make earlier diagnoses, in addition to just having an awareness of these entities,” she says. 

“We hope for psoriatic disease and rheumatoid arthritis to be a chronic, manageable illness,” says Dr. Calabrese. “We want this disease to be on the back burner of patients’ lives, and we want to diagnose early and treat it early.” 

Looking for Answers?

Get the latest news, tips, and inspiring stories from experts, advocates, and people like you.

Sign up for the newsletter

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logoTwill Care logo

Copyright © 1996-2022 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.